168 related articles for article (PubMed ID: 15617645)
1. [Expert Consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease].
López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C; Priori SG; Alonso García MA; Blanc JJ; Budaj A; Cowie M; Dean V; Deckers J; Fernández Burgos E; Lekakis J; Lindahl B; Mazzotta G; McGregor K; Morais J; Oto A; Smiseth OA; Ardissino D; Avendano C; Blomström-Lundqvist C; Clément D; Drexler H; Ferrari R; Fox KA; Julian D; Kearney P; Klein W; Köber L; Mancia G; Nieminen M; Ruzillo W; Simoons M; Thygesen K; Tognoni G; Tritto I; Wallentin L; ;
Rev Esp Cardiol; 2004 Dec; 57(12):1213-32. PubMed ID: 15617645
[No Abstract] [Full Text] [Related]
2. The role of ACE inhibitor therapy in treating cardiovascular disease.
Flint L
Nurs Times; 2004 Mar 23-29; 100(12):34-7. PubMed ID: 15067910
[TBL] [Abstract][Full Text] [Related]
3. [The long way of angiotensin-converting enzyme inhibitors in the fight against cardiovascular diseases].
Ferrari R; Ambrosio G; Chiariello M
Ital Heart J; 2005 Nov; 6 Suppl 7():3S-4S. PubMed ID: 16485511
[No Abstract] [Full Text] [Related]
4. The future: cardiovascular medicine in 10 years.
Swedberg K
Heart; 2000 Sep; 84 Suppl 1(Suppl 1):i48-9; discussion i50. PubMed ID: 10956324
[No Abstract] [Full Text] [Related]
5. Ramipril.
Smith WH; Ball SG
Int J Clin Pract; 2000 May; 54(4):255-60. PubMed ID: 10912316
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme inhibitors for hypertension and heart failure?
Cleland JG
Postgrad Med J; 1992 Jan; 68(795):1-5. PubMed ID: 1561182
[No Abstract] [Full Text] [Related]
7. Angiotensin receptor blockers: novel role in high-risk patients.
Javed U; Deedwania PC
Cardiol Clin; 2008 Nov; 26(4):507-26. PubMed ID: 18929228
[TBL] [Abstract][Full Text] [Related]
8. The use of ACE inhibitor in cardiovascular disease.
Nasution SA
Acta Med Indones; 2006; 38(1):60-4. PubMed ID: 16479034
[TBL] [Abstract][Full Text] [Related]
9. [Angiotensin-converting enzyme inhibition and cardiovascular prevention: more than twenty years of clinical success].
Borghi C; Cosentino E; De Sanctis D
Ital Heart J Suppl; 2005 Dec; 6(12):769-79. PubMed ID: 16444921
[TBL] [Abstract][Full Text] [Related]
10. Expert consensus document on angiotensin converting enzyme inhibitors in cardiovascular disease. The Task Force on ACE-inhibitors of the European Society of Cardiology.
López-Sendón J; Swedberg K; McMurray J; Tamargo J; Maggioni AP; Dargie H; Tendera M; Waagstein F; Kjekshus J; Lechat P; Torp-Pedersen C;
Eur Heart J; 2004 Aug; 25(16):1454-70. PubMed ID: 15302105
[No Abstract] [Full Text] [Related]
11. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
Rapezzi C; Ciliberti P; Graziosi M; Riva L
Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme inhibitors as cardioprotective agents.
Massie BM
Am J Cardiol; 1992 Dec; 70(21):10I-17I. PubMed ID: 1471600
[TBL] [Abstract][Full Text] [Related]
13. [The heart of the matter in cardiovascular therapy. ACE-inhibition with Quinapril: hypertension, myocardial infarction, cardiac insufficiency].
Fortschr Med Monogr; 1993; 68():1-23. PubMed ID: 7728496
[No Abstract] [Full Text] [Related]
14. Cardioprotection and ACE inhibitors.
Ball SG
Clin Physiol Biochem; 1992; 9(3):98-104. PubMed ID: 1302164
[TBL] [Abstract][Full Text] [Related]
15. [Efficacy of angiotensin-converting enzyme inhibitors in secondary prevention].
Ceconi C; Mastrorilli F; Squasi PA; Gaitani S; Guardigli G; Ferrari R
Ital Heart J; 2005 Nov; 6 Suppl 7():5S-13S. PubMed ID: 16485512
[TBL] [Abstract][Full Text] [Related]
16. Current indications for ACE inhibitors and HOPE for the future.
Burch S; Ou N
Am J Manag Care; 2002 May; 8(5):478-90; quiz 491-3. PubMed ID: 12019599
[TBL] [Abstract][Full Text] [Related]
17. Using ACE inhibitors appropriately.
Bicket DP
Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
[TBL] [Abstract][Full Text] [Related]
18. ACE inhibitors in cardiovascular disease. Which patient? Which drug? Which dose?
Pellizzer AM; Krum H
Aust Fam Physician; 1996 Jul; 25(7):1067-9, 1072-3, 1076-7. PubMed ID: 8768273
[TBL] [Abstract][Full Text] [Related]
19. Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease?
Doggrell SA
Expert Opin Pharmacother; 2002 Nov; 3(11):1543-56. PubMed ID: 12437489
[TBL] [Abstract][Full Text] [Related]
20. Tissue angiotensin-converting enzyme inhibitors: are they more effective than serum angiotensin-converting enzyme inhibitors?
Shah AD; Arora RR
Clin Cardiol; 2005 Dec; 28(12):551-5. PubMed ID: 16405197
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
